BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Pasciak AS, Abiola G, Liddell RP, Crookston N, Besharati S, Donahue D, Thompson RE, Frey E, Anders RA, Dreher MR, Weiss CR. The number of microspheres in Y90 radioembolization directly affects normal tissue radiation exposure. Eur J Nucl Med Mol Imaging 2020;47:816-27. [PMID: 31741021 DOI: 10.1007/s00259-019-04588-x] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 De la Garza-Ramos C, Toskich BB. Radioembolization for the Treatment of Hepatocellular Carcinoma: The Road to Personalized Dosimetry and Ablative Practice. Semin Intervent Radiol 2021;38:466-71. [PMID: 34629715 DOI: 10.1055/s-0041-1735571] [Reference Citation Analysis]
2 Chiesa C, Sjogreen-Gleisner K, Walrand S, Strigari L, Flux G, Gear J, Stokke C, Gabina PM, Bernhardt P, Konijnenberg M. EANM dosimetry committee series on standard operational procedures: a unified methodology for 99mTc-MAA pre- and 90Y peri-therapy dosimetry in liver radioembolization with 90Y microspheres. EJNMMI Phys 2021;8:77. [PMID: 34767102 DOI: 10.1186/s40658-021-00394-3] [Reference Citation Analysis]
3 Maxwell AWP, Mendoza HG, Sellitti MJ, Camacho JC, Deipolyi AR, Ziv E, Sofocleous CT, Yarmohammadi H, Maybody M, Humm JL, Schwartz J, Juluru K, Dunphy MP, Boas FE. Optimizing 90Y Particle Density Improves Outcomes After Radioembolization. Cardiovasc Intervent Radiol 2022. [PMID: 35459960 DOI: 10.1007/s00270-022-03139-6] [Reference Citation Analysis]
4 Hesse M, d'Abadie P, Lhommel R, Jamar F, Walrand S. Yttrium-90 TOF-PET-Based EUD Predicts Response Post Liver Radioembolizations Using Recommended Manufacturer FDG Reconstruction Parameters. Front Oncol 2021;11:592529. [PMID: 34676157 DOI: 10.3389/fonc.2021.592529] [Reference Citation Analysis]
5 Aramburu J, Antón R, Rodríguez-Fraile M, Sangro B, Bilbao JI. Computational Fluid Dynamics Modeling of Liver Radioembolization: A Review. Cardiovasc Intervent Radiol 2022;45:12-20. [PMID: 34518913 DOI: 10.1007/s00270-021-02956-5] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Roosen J, Klaassen NJM, Westlund Gotby LEL, Overduin CG, Verheij M, Konijnenberg MW, Nijsen JFW. To 1000 Gy and back again: a systematic review on dose-response evaluation in selective internal radiation therapy for primary and secondary liver cancer. Eur J Nucl Med Mol Imaging 2021. [PMID: 33839892 DOI: 10.1007/s00259-021-05340-0] [Reference Citation Analysis]
7 Chiesa C, Mazzaglia S, Maccauro M. Spatial density and tumor dosimetry are important in radiation segmentectomy with 90Y glass microspheres. Eur J Nucl Med Mol Imaging 2022. [PMID: 35543732 DOI: 10.1007/s00259-022-05819-4] [Reference Citation Analysis]
8 Gordon AC, Gates VL, White SB, Harris KR, Procissi D, Zhang Z, Li W, Samaan D, Nicolai JR, Mouli SK, Sato KT, Ryu RK, Omary RA, Salem R, Lewandowski RJ, Larson AC. Correlation and Agreement of Yttrium-90 Positron Emission Tomography/Computed Tomography with Ex Vivo Radioembolization Microsphere Deposition in the Rabbit VX2 Liver Tumor Model. J Vasc Interv Radiol 2021;32:23-32.e1. [PMID: 33189539 DOI: 10.1016/j.jvir.2020.09.016] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
9 Young S, Chen T, Flanagan S, Golzarian J, Sanghvi T. Realized tumor to normal ratios in hepatocellular carcinoma patients undergoing transarterial radioembolization: a retrospective evaluation. Eur Radiol 2022. [PMID: 35032212 DOI: 10.1007/s00330-021-08501-9] [Reference Citation Analysis]
10 Romanò C, Mazzaglia S, Maccauro M, Spreafico C, Gabutti A, Maffi G, Morosi C, Cascella T, Mira M, De Nile MC, Aliberti G, Argiroffi G, Fuoco V, Bhoori S, Zanette C, Marchianò A, Seregni E, Mazzaferro V, Chiesa C. Radioembolization of Hepatocellular Carcinoma with 90Y Glass Microspheres: No Advantage of Voxel Dosimetry with Respect to Mean Dose in Dose-Response Analysis with Two Radiological Methods. Cancers (Basel) 2022;14:959. [PMID: 35205712 DOI: 10.3390/cancers14040959] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
11 Alsultan AA, Braat AJAT, Smits MLJ, Barentsz MW, Bastiaannet R, Bruijnen RCG, de Keizer B, de Jong HWAM, Lam MGEH, Maccauro M, Chiesa C. Current Status and Future Direction of Hepatic Radioembolisation. Clin Oncol (R Coll Radiol) 2021;33:106-16. [PMID: 33358630 DOI: 10.1016/j.clon.2020.12.003] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
12 Pasciak AS, Manupipatpong S, Hui FK, Gainsburg L, Krimins R, Zink MC, Brayton CF, Morris M, Sage J, Donahue DR, Dreher MR, Kraitchman DL, Weiss CR. Yttrium-90 radioembolization as a possible new treatment for brain cancer: proof of concept and safety analysis in a canine model. EJNMMI Res 2020;10:96. [PMID: 32804262 DOI: 10.1186/s13550-020-00679-1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
13 Mouli SK, Raiter S, Harris K, Mylarapu A, Burks M, Li W, Gordon AC, Khan A, Matsumoto M, Bailey KL, Pasciak AS, Manupipatpong S, Weiss CR, Casalino D, Miller FH, Gates VL, Hohlastos E, Lewandowski RJ, Kim DH, Dreher MR, Salem R. Yttrium-90 Radioembolization to the Prostate Gland: Proof of Concept in a Canine Model and Clinical Translation. J Vasc Interv Radiol 2021;32:1103-1112.e12. [PMID: 33839262 DOI: 10.1016/j.jvir.2021.01.282] [Reference Citation Analysis]
14 d'Abadie P, Hesse M, Louppe A, Lhommel R, Walrand S, Jamar F. Microspheres Used in Liver Radioembolization: From Conception to Clinical Effects. Molecules 2021;26:3966. [PMID: 34209590 DOI: 10.3390/molecules26133966] [Reference Citation Analysis]
15 Henry EC, Strugari M, Mawko G, Brewer KD, Abraham R, Kappadath SC, Syme A. Post-administration dosimetry in yttrium-90 radioembolization through micro-CT imaging of radiopaque microspheres in a porcine renal model. Phys Med Biol 2021;66. [PMID: 33784639 DOI: 10.1088/1361-6560/abf38a] [Reference Citation Analysis]
16 d'Abadie P, Walrand S, Hesse M, Annet L, Borbath I, Van den Eynde M, Lhommel R, Jamar F. Prediction of tumor response and patient outcome after radioembolization of hepatocellular carcinoma using 90Y-PET-computed tomography dosimetry. Nucl Med Commun 2021;42:747-54. [PMID: 33741864 DOI: 10.1097/MNM.0000000000001395] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]